Page 5,220«..1020..5,2195,2205,2215,222..5,2305,240..»

Dispute Flares Inside FDA Over Safety of Popular Blood-Pressure Drugs

Posted: Published on May 31st, 2013

The top-selling class of blood-pressure drugs is under attack from an unusual source: a senior regulator at the Food and Drug Administration. Bucking his bosses, Thomas A. Marciniak is seeking stronger warnings about the drugs known as angiotensin receptor blockers, or ARBs, according to internal documents reviewed by The Wall Street Journal. The drugs, which are taken by millions of people and generated $7.6 billion in U.S. sales in 2012, may be linked to higher cancer rates, Dr. Marciniak argues, a view shared by some outside doctors. Top FDA officials say evidence doesn't support a link. The debate over ARBs highlights the question of whether the U.S. drug-safety agency devotes enough effort to examining the safety of long-marketed blockbusters as it focuses on new drugs. In a rare rebellion by an FDA reviewer, Dr. Marciniak has clashed with his bosses over his desire to spend time on ARB safety, instead of just on new-drug applications. Ellis Unger, chief of the drug-evaluation division that includes Dr. Marciniak, called the complaints a "diversion," and said in an interview, "We have no reason to tell the public anything new." ARBs on the market in the U.S. include Novartis AG's Diovan, Daiichi Sankyo Co.'s … Continue reading →

Posted in Drugs | Comments Off on Dispute Flares Inside FDA Over Safety of Popular Blood-Pressure Drugs

Greys River plan fails — Buy Vantin Online Without Prescription » Online Pharmacy

Posted: Published on May 31st, 2013

By Sarah Hale on May 30, 2013 in Alpine, Featured, News The Lincoln County Planning and Zoning Commission failed to approve a Planned Unit Development master plan for the Blind Bull area of Greys River. The action took place Wednesday, May 29 at the regular Planning and Zoning Commission Meeting in Cokeville. Following presentations by Planning Director John Woodward and Mark Nicoll, representing the Blind Bull Meadows Project, a public hearing on the project was held. A crowd of concerned citizens participated in the discussion sharing either concern about or support for the project. At the close of the hearing, the Planning and Zoning Commission failed to approve the master plan in a tied vote, two in favor and two opposed. Blake Nield and Val Clement voted against the approval. Robert Zakotnik and Roger King voted in favor. Scott Moyes was absent from the meeting. The proposal will go before the Lincoln County Commissioners on Wednesday, June 5 at 9 a.m. in Kemmerer. Originally posted here: Greys River plan fails — Buy Vantin Online Without Prescription » Online Pharmacy … Continue reading →

Posted in Online Pharmacy | Comments Off on Greys River plan fails — Buy Vantin Online Without Prescription » Online Pharmacy

Elkton Friendly Pharmacy Video | Pharmacy in Elkton – Video

Posted: Published on May 31st, 2013

Elkton Friendly Pharmacy Video | Pharmacy in Elkton http://my.datasphere.com/biz/elkton_friendly_pharmacy-health_beauty_pharmacies-elkton_md-12563817-219505 Elkton Friendly Pharmacy provides quality medicine a... By: DataSphereVideos … Continue reading →

Posted in Pharmacy | Comments Off on Elkton Friendly Pharmacy Video | Pharmacy in Elkton – Video

Pharmacy Professor Shares Secrets Of Traditional Healing – Video

Posted: Published on May 31st, 2013

Pharmacy Professor Shares Secrets Of Traditional Healing Many modern medicines have their origins in natural remedies. And some researchers say traditional herbal cures hold clues for more medical advances. VOA's M... By: VOAvideo … Continue reading →

Posted in Pharmacy | Comments Off on Pharmacy Professor Shares Secrets Of Traditional Healing – Video

CDC: ‘Multistate outbreak’ from drugs linked to Tenn. pharmacy

Posted: Published on May 31st, 2013

Federal and state regulators announced last week that seven people had developed infections after receiving a steroid made at a Tennessee compounding pharmacy. The total is now up to 20 cases in three states, and the CDC has labelled it an outbreak. The agency said on its website that most reports were of skin and soft tissue infections of unclear etiology. There have been no reports of meningitis or life-threatening infections. The new outbreak is far less severe than the one involving New England Compounding, but there are commonalities. Both were caused by injectable methylprednisolone acetate, used to treat pain and inflammation, and both involved compounding pharmacies that are supposed to make sterile, individualized drugs for patients who need special doses or formulations. New England Compounding was operating beyond that scope by producing large batches, more like a drug manufacturer, and in unclean facilities, regulators found. Tennessee was among the states hardest hit by that outbreak, with 15 deaths. The latest issue, involving Main Street Family Pharmacy, in Newbern, Tenn., has affected patients in Florida, Illinois, and North Carolina. The Tennessean reported that the company has surrendered its license to operate in North Carolina, where patients have had skin abscesses. … Continue reading →

Posted in Pharmacy | Comments Off on CDC: ‘Multistate outbreak’ from drugs linked to Tenn. pharmacy

Study coaxes clays to make human bone

Posted: Published on May 31st, 2013

May 30, 2013 Weak bones, broken bones, damaged bones, arthritic bones. Whether damaged by injury, disease or age, your body can't create new bone, but maybe science can. Researchers at North Dakota State University, Fargo, are making strides in tissue engineering, designing scaffolds that may lead to ways to regenerate bone. Published in the Journal of Biomedical Materials Research Part A, the research of Dr. Kalpana Katti, Dr. Dinesh Katti and graduate student Avinash Ambre includes a novel method that uses nanosized clays to make scaffolds to mineralize bone minerals such as hydroxyapatite. The NDSU research team's 3-D mesh scaffold is composed of degradable materials that are compatible to human tissue. Over time, the cells generate bone and the scaffold deteriorates. As indicated in the NDSU team's published scientific research from 2008 to 2013, the nanoclays enhance the mechanical properties of the scaffold by enabling scaffold to bear load while bone generates. An interesting finding by the Katti group has shown that the nanoclays also impart useful biological properties to the scaffold. "The biomineralized nanoclays also impart osteogenic or bone-forming abilities to the scaffold to enable birth of bone," said Dr. Kalpana Katti, Distinguished Professor of civil engineering at NDSU. … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Study coaxes clays to make human bone

Osiris Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference

Posted: Published on May 31st, 2013

COLUMBIA, Md.--(BUSINESS WIRE)-- Osiris Therapeutics, Inc. (OSIR), the leading stem cell company focused on developing and marketing products to treat medical conditions in inflammatory, cardiovascular, orthopedic and wound healing markets, announced today that C. Randal Mills, Ph.D., President and Chief Executive Officer, is scheduled to present at the Jefferies 2013 Global Healthcare Conference on Monday, June 3, 2013 at 4:00 p.m. ET in New York City. A live webcast of the presentation may be accessed through the Investors page of the Companys website at http://www.Osiris.com. A replay of the webcast will be available for one week following the conference. About Osiris Therapeutics Osiris Therapeutics, Inc., is the leading stem cell company, having developed the worlds first approved stem cell drug, Prochymal. Osiris currently markets Grafix and Ovation for wound and tissue repair, and CartiformTM for cartilage repair. Osiris is a fully integrated company with capabilities in research, development, manufacturing and distribution of cell therapy products. Osiris has developed an extensive intellectual property portfolio to protect the company's technology, including 50 U.S. and 156 foreign patents. Osiris, Prochymal, Chondrogen, Grafix and Ovation are registered trademarks of Osiris Therapeutics, Inc. More information can be found on the company's website, http://www.Osiris.com. (OSIR-G) Forward-Looking … Continue reading →

Posted in Mesenchymal Stem Cells | Comments Off on Osiris Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference

MDA Awards Valerion Therapeutics $1.2 Million to Continue Myotubular Myopathy Research

Posted: Published on May 31st, 2013

Tucson, Ariz. (PRWEB) May 30, 2013 The Muscular Dystrophy Association has awarded Valerion Therapeutics $1,195,762 to continue development of an experimental cell-penetrating treatment that may represent a unique approach to treating myotubular myopathy (MTM). The experimental treatment, 3E10Fv-MTM1, uses a cell-penetrating antibody to deliver myotubularin to muscle fibers. Myotubularin is the protein that is deficient in MTM1. Researchers at the Concord, Mass., biotech have taken a different approach to creating an effective enzyme-replacement therapy by utilizing an antibody-protein fusion that can penetrate the muscle cell. After receiving injections of 3E10Fv-MTM1 for only two weeks, mice showed improved muscle strength, function and structure. We are interested in this technology because it may provide a novel method of delivering proteins to muscle, said MDA Vice President of Research Jane Larkindale. In January, the company published data that showed that the technology allowed the protein to get into the muscles of a mouse model of the disease, where it had a positive effect on the disease course. It also may be able to be applied to other proteins for other diseases in MDA's program." MTM is an inherited muscle disease that can cause severe, general muscle weakness complicating basic activities such as breathing … Continue reading →

Posted in Muscular Dystrophy Treatment | Comments Off on MDA Awards Valerion Therapeutics $1.2 Million to Continue Myotubular Myopathy Research

SABIC donates SR 45 m for autism research

Posted: Published on May 31st, 2013

A SR 45-million Autism Research Center (ARC) was inaugurated in Riyadh on Tuesday at the King Faisal Specialist Hospital and Research Center (KFSHRC). The donor, Saudi Basic Industries Corporation (SABIC), said the donation aims to support ARCs research on autism in terms of educational and medical aspects. It will also create training programs to raise the level of services provided for autistic patients in the Kingdom. The launch was attended by SABIC Chairman Prince Saud bin Abdullah bin Thunayan Al-Saud, who said that Custodian of the Two Holy Mosques King Abdullah is keen on providing quality care to people with autism. Autism is a complex disorder of brain development characterized in varying degrees by difficulties in social interaction, verbal and non-verbal communication and repetitive behavior, generally targeting children in their young age. He said: This center will be an important added value to strengthen the existing efforts in the field of research of autism in Saudi Arabia, the Gulf region and the Middle East. He added that the King Faisal Specialist Hospital is one of the most vital service-providers specializing in this category of patients. He expressed confidence in the capabilities of the center's team, adding that its medical care … Continue reading →

Comments Off on SABIC donates SR 45 m for autism research

Word Tests at Age 2 Might Predict Gains for Kids With Autism, Study Finds

Posted: Published on May 31st, 2013

Latest Mental Health News WEDNESDAY, May 29 (HealthDay News) -- Early brain responses to words may help predict future abilities in children with autism, a new study suggests. "We showed that a simple measure of how the brain responds to a familiar word taken at 2 years of age was a strong predictor of children's language, social and cognitive abilities ... at 6 years of age," said study co-author Geraldine Dawson, chief science officer at the advocacy group Autism Speaks. Autism is a neurodevelopmental disorder characterized by impaired communication, difficulty with social interactions and repetitive behaviors. The U.S. Centers for Disease Control and Prevention estimates that one in 88 U.S. children has some form of autism, which can range from mild to severe. "In this study, we were interested in understanding why some children with autism make rapid progress whereas others progress more slowly," Dawson said. "For example, many children with autism are able to develop spoken language, whereas about 20 percent to 30 percent remain minimally verbal or nonverbal. "Recent studies have shown that nonverbal children can be helped to develop spoken language if they are given special alternative devices -- such as an iPad or other speech-generating device … Continue reading →

Comments Off on Word Tests at Age 2 Might Predict Gains for Kids With Autism, Study Finds

Page 5,220«..1020..5,2195,2205,2215,222..5,2305,240..»